EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access

Dependent censoring bias assessment using inverse probability of censoring weights: Type 2 diabetes mellitus risk in patients initiating bisoprolol versus other antihypertensives in a Clinical Practice Research Datalink cohort study

Antoine Pinon iD, Arthur Allignol iD, Thilo Hohenberger, Caroline Foch iD, Emmanuelle Boutmy iD, Ulrike Hostalek

Journal of Comparative Effectiveness Research · 2024

DOI: 10.57264/cer-2023-0027 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Comparative Effectiveness Research, 2024. Verfasst von Antoine Pinon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Arthur Allignol & Antoine Pinon were employed by Merck Healthcare KGaA, Darmstadt, Germany. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Bisoprolol, Antihypertensive Agents, Hypertension. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dependent censoring involves a preferential attrition of a subgroup of interest; occurring in survival analysis, it may impact interpretation by introducing a selection bias. To assess the potential bias in a comparison of bisoprolol to other antihypertensives in terms of Type 2 diabetes mellitus (T2DM) incidence, inverse probability of censoring weights (IPCW) was used. It was further used to contextualize results obtained through competing risks analysis. Two estimands were considered to assess T2DM incidence while accounting for deviations from the initial antihypertensive monotherapy (DFM). A hypothetical estimand using IPCW, treating DFM as censoring, was interpreted together with a ‘while-on-treatment’ estimand, treating DFM as a competing risk. We illustrated our application with a cohort study based on Clinical Practice Research Datalink (CPRD) including 267,352 patients with newly diagnosed arterial hypertension between 2000 and 2017, initiating antihypertensive monotherapy among bisoprolol, other beta-blockers, renin-angiotensin system drugs (ACEi/ARB), diuretics and calcium-channel blockers. A mild dependent censoring process was hypothesized, leading to slight overestimation of T2DM incidence. Although subject to some limitations, a nonsignificant trend toward an excess of risk associated with ACEi/ARB was yielded consistently by IPCW and competing risks analyses. Conversely, in comparisons of bisoprolol versus either diuretics, other beta-blockers or calcium channel blockers, no significant differences or critical dependent censoring impact were found. Concurrent use of complementary estimands allowed formulating a refined interpretation of our findings: though not significant, the trend toward an excess of T2DM risk associated with a ACEi/ARB monotherapy compared with bisoprolol is likely not originating only from the minor dependent censoring. Reassessing identical estimands in other cohorts would provide insights to corroborate or refute this result.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2BisoprololAntihypertensive AgentsHypertensionHumansFemaleMiddle AgedMaleAgedCohort StudiesIncidenceBiasRisk AssessmentAdult

Stichwörter der Autor:innen

CPRDIPCWType 2 diabetes mellitusantihypertensive therapybisoprololcensoring biasreal-world evidence

Substanzen

BisoprololAntihypertensive Agents

Autor:innen und Institutionen

  • Arthur Allignol & Antoine Pinon were employed by Merck Healthcare KGaA, Darmstadt, Germany.
  • Merck Healthcare KGaA, Darmstadt, Germany.

ORCID-Profile: Antoine Pinon, Arthur Allignol, Caroline Foch, Emmanuelle Boutmy

Zitieren

APA

Pinon, A., Allignol, A., Hohenberger, T., Foch, C., Boutmy, E., & Hostalek, U. (2024). Dependent censoring bias assessment using inverse probability of censoring weights: Type 2 diabetes mellitus risk in patients initiating bisoprolol versus other antihypertensives in a Clinical Practice Research Datalink cohort study. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2023-0027

Vancouver

Pinon A, Allignol A, Hohenberger T, Foch C, Boutmy E, Hostalek U. Dependent censoring bias assessment using inverse probability of censoring weights: Type 2 diabetes mellitus risk in patients initiating bisoprolol versus other antihypertensives in a Clinical Practice Research Datalink cohort study. Journal of Comparative Effectiveness Research. 2024. doi:10.57264/cer-2023-0027

BibTeX
@article{Pinon2024,
  author = {Pinon, Antoine and Allignol, Arthur and Hohenberger, Thilo and Foch, Caroline and Boutmy, Emmanuelle and Hostalek, Ulrike},
  title = {Dependent censoring bias assessment using inverse probability of censoring weights: Type 2 diabetes mellitus risk in patients initiating bisoprolol versus other antihypertensives in a Clinical Practice Research Datalink cohort study},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2024},
  doi = {10.57264/cer-2023-0027}
}
Kostenlos starten →